These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21216118)

  • 101. Psychosis associated with interferon alfa therapy for chronic hepatitis B.
    Tamam L; Yerdelen D; Ozpoyraz N
    Ann Pharmacother; 2003 Mar; 37(3):384-7. PubMed ID: 12639168
    [TBL] [Abstract][Full Text] [Related]  

  • 102. [Prevalence and clinical characteristics of thyroid disease induced by chronic hepatitis B treated with polyethylene glycol (peg) interferon-alpha].
    Chen XF; Chen XP; Ma XJ; Chen WL; Huang J; Luo XD
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Apr; 26(2):117-9. PubMed ID: 23002550
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Concurrent polycythemia vera and chronic lymphocytic leukemia: treatment response to pegylated interferon alpha 2a.
    Selinger HA; Ballesteros E; Bona R
    Am J Hematol; 2013 Jun; 88(6):535-6. PubMed ID: 23553722
    [No Abstract]   [Full Text] [Related]  

  • 104. Sudden hearing loss associated with interferon.
    Kanda Y; Shigeno K; Kinoshita N; Nakao K; Yano M; Matsuo H
    Lancet; 1994 May; 343(8906):1134-5. PubMed ID: 7910234
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Experience with pegylated interferon α-2a in advanced myeloproliferative neoplasms in an international cohort of 118 patients.
    Gowin K; Thapaliya P; Samuelson J; Harrison C; Radia D; Andreasson B; Mascarenhas J; Rambaldi A; Barbui T; Rea CJ; Camoriano J; Gentry A; Kiladjian JJ; O'Connell C; Mesa R
    Haematologica; 2012 Oct; 97(10):1570-3. PubMed ID: 22419578
    [TBL] [Abstract][Full Text] [Related]  

  • 106. The effects of pegylated interferon--alpha2B on mumps orchitis.
    Pal G
    J Indian Med Assoc; 2013 Sep; 111(9):612-4, 617. PubMed ID: 24968526
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Thyroid dysfunction incidence and risk factors in Chinese chronic hepatitis B patients treated with pegylated interferon alpha: A long-term follow-up study.
    Ma Z; Qin Y; Jia Y; Xie Y; Qi X; Guo Y; He J; Zhang Y; Li F; Yu J; Zhu H; Yang F; Zhang Y; Mao R; Zhang J
    J Viral Hepat; 2022 Jun; 29(6):412-419. PubMed ID: 35293082
    [TBL] [Abstract][Full Text] [Related]  

  • 108. A study of the pharmacokinetic interaction between lamivudine and alpha interferon.
    Johnson MA; Jenkins JM; Bye C
    Eur J Clin Pharmacol; 2000 Jul; 56(4):289-92. PubMed ID: 10954341
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Effects of lamivudine therapy on the glucose metabolism in children with chronic hepatitis B: first year follow-up results.
    Ertekin V; Selimoğlu MA; Orbak Z
    Eur J Gastroenterol Hepatol; 2005 Jun; 17(6):655-9. PubMed ID: 15879728
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Death possibly associated with interferon use in a patient with chronic hepatitis.
    Kendirli T; Kismet E; Demirkaya E; Aydin HI; Kesik V; Köseoğlu V
    Acta Paediatr; 2005 Jul; 94(7):984-5. PubMed ID: 16188832
    [No Abstract]   [Full Text] [Related]  

  • 111. [Comparative study of the time period between the initiation of various interferon therapies and the onset of suicide- or diabetes-related side effect].
    Kobayashi T
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2013; (131):45-9. PubMed ID: 24340669
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Tolerability of treatments for viral hepatitis.
    Gervais A; Boyer N; Marcellin P
    Drug Saf; 2001; 24(5):375-84. PubMed ID: 11419564
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Investigation of the ototoxic effects of interferon alpha2A on the mouse cochlea.
    Akyol MU; Sarac S; Akyol G; Atac A; Poyraz A; Belgin E; Turan E
    Otolaryngol Head Neck Surg; 2001 Jan; 124(1):107-10. PubMed ID: 11228464
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Interferon-induced sudden hearing loss.
    Kanda Y; Shigeno K; Matsuo H; Yano M; Yamada N; Kumagami H
    Audiology; 1995; 34(2):98-102. PubMed ID: 8561688
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Non-pegylated and Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma and the Risk of Severe Ocular Side-effects.
    Albrecht JD; Ninosu N; Barry D; Albrecht T; Schaarschmidt ML; Goerdt S; Nicolay JP
    Acta Derm Venereol; 2022 May; 102():adv00722. PubMed ID: 35506362
    [No Abstract]   [Full Text] [Related]  

  • 116. Cognitive effects of pegylated interferon in individuals with primary brain tumors.
    Dickinson MD; Barr CD; Hiscock M; Meyers CA
    J Neurooncol; 2009 Nov; 95(2):231-237. PubMed ID: 19484406
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Intravenous administration of levodopa ameliorated a refractory akathisia case induced by interferon-alpha.
    Sunami M; Nishikawa T; Yorogi A; Shimoda M
    Clin Neuropharmacol; 2000; 23(1):59-61. PubMed ID: 10682234
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Acute vestibular dysfunction associated with interferon-alpha therapy.
    Murofushi T; Takeuchi N; Ozeki H; Mizuno M
    Eur Arch Otorhinolaryngol; 1998; 255(2):77-8. PubMed ID: 9550261
    [No Abstract]   [Full Text] [Related]  

  • 119. Interferon-alpha-induced mood disorder with manic features.
    Altindag A; Ozbulut O; Ozen S; Ucmak H
    Gen Hosp Psychiatry; 2001; 23(3):168-70. PubMed ID: 11447988
    [No Abstract]   [Full Text] [Related]  

  • 120. Audiometric and vestibular evaluation in women using the hormonal contraceptive method.
    Mitre EI; Figueira AS; Rocha AB; Alves SM
    Braz J Otorhinolaryngol; 2006; 72(3):350-4. PubMed ID: 17119770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.